Biochemical and Biological Characterization of Naja Kaouthia Venom from North-East India and Its Neutralization by Polyvalent Antivenom

Overview

Journal J Venom Res

Date 2013 Dec 19

PMID 24349704

Citations 17

Authors

Diganta Das

Nanjaraj Urs

Vilas Hiremath

Bannikuppe Sannanaik Vishwanath

Robin Doley

Affiliations

Soon will be listed here.

Abstract

This study describes biochemical and biological properties of Naja kaouthia (Indian monocled cobra) venom of North-East India. The LD50 of the crude venom was found to be 0.148mg/kg and neurotoxicitic symptoms like paralysis of lower limbs and heavy difficulty in breathing at sub-lethal dose in mice was observed. The venom exhibited PLA2, indirect hemolytic and myotoxic activities but showed weak proteolytic and low direct hemolytic activities. It did not exhibit any hemorrhage when injected intradermally to mice. Anticoagulant activity was prominent when recalcification, prothrombin and activated partial thrombinplastin time were tested on platelet poor plasma. Rotem analysis of whole citrated blood in presence of venom showed delay in coagulation time and clot formation time. Fibrinogen of whole citrated blood was depleted by venom when analyzed in Sonoclot. Crude venom at 10µg and after 16hr of incubation was found to degrade α chain of fibrinogen. Neutralization study showed that Indian polyvalent antivenom could neutralize some of the biochemical and biological activities as well as its fibrinogenolytic activity.

Citing Articles

Respiratory Muscle Injury Following Acute Monocled Cobra () Envenoming: Histopathological Study in Rat Diaphragm.

Chuaikhongthong W, Khimmaktong W, Thipthong N, Lorthong N, Chaisakul J Curr Issues Mol Biol. 2025; 47(2).

PMID: 39996807 PMC: 11854468. DOI: 10.3390/cimb47020086.

Therapeutic potency of kaempferol against Naja haje venom induced neurotoxicity, inflammation, biological activities, and antioxidant system damage: a pre-clinical antivenom evaluation.

Ajisebiola B, Adeniyi B, Alakoso M, Fapohunda S, Nwanze K, Adeyi A Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39621086 DOI: 10.1007/s00210-024-03678-4.

Biochemical and biological characterization of the venoms of and from Myanmar and neutralization effects of BPI cobra antivenom.

Win M, Yee K, Htwe K, Thin E, Win S, Kyaw A Toxicon X. 2024; 22:100196.

PMID: 38665175 PMC: 11043865. DOI: 10.1016/j.toxcx.2024.100196.

Development of aqueous two-phase systems-based approaches for the selective recovery of metalloproteases and phospholipases A toxins from Crotalus molossus nigrescens venom.

Enriquez-Ochoa D, Melendez-Martinez D, Aguilar-Yanez J, Licona-Cassani C, Mayolo-Deloisa K Bioresour Bioprocess. 2024; 8(1):136.

PMID: 38650265 PMC: 10992436. DOI: 10.1186/s40643-021-00487-y.

Systematic review and meta-analysis on the efficacy of Indian polyvalent antivenom against the Indian snakes of clinical significance.

Gopal G, Selvaraj H, Venkataramanan S, Venkataraman S, Saravanan K, Bibina C Arch Toxicol. 2023; 98(2):375-393.

PMID: 38153416 DOI: 10.1007/s00204-023-03643-9.

References

Ouyang C, Teng C . Fibrinogenolytic enzymes of Trimeresurus mucrosquamatus venom. Biochim Biophys Acta. 1976; 420(2):298-308. DOI: 10.1016/0005-2795(76)90321-4. View

Williams D, Jensen S, Nimorakiotakis B, Muller R, Winkel K . Antivenom use, premedication and early adverse reactions in the management of snake bites in rural Papua New Guinea. Toxicon. 2007; 49(6):780-92. DOI: 10.1016/j.toxicon.2006.11.026. View

Shashidharamurthy R, Kemparaju K . Region-specific neutralization of Indian cobra (Naja naja) venom by polyclonal antibody raised against the eastern regional venom: A comparative study of the venoms from three different geographical distributions. Int Immunopharmacol. 2006; 7(1):61-9. DOI: 10.1016/j.intimp.2006.08.014. View

Leong P, Sim S, Fung S, Sumana K, Sitprija V, Tan N . Cross neutralization of Afro-Asian cobra and Asian krait venoms by a Thai polyvalent snake antivenom (Neuro Polyvalent Snake Antivenom). PLoS Negl Trop Dis. 2012; 6(6):e1672. PMC: 3367981. DOI: 10.1371/journal.pntd.0001672. View

Menezes M, Furtado M, Travaglia-Cardoso S, Camargo A, Serrano S . Sex-based individual variation of snake venom proteome among eighteen Bothrops jararaca siblings. Toxicon. 2005; 47(3):304-12. DOI: 10.1016/j.toxicon.2005.11.007. View

Joseph J, Simpson I, Menon N, Jose M, Kulkarni K, Raghavendra G . First authenticated cases of life-threatening envenoming by the hump-nosed pit viper (Hypnale hypnale) in India. Trans R Soc Trop Med Hyg. 2006; 101(1):85-90. DOI: 10.1016/j.trstmh.2006.03.008. View

Kerns R, Kini R, Stefansson S, Evans H . Targeting of venom phospholipases: the strongly anticoagulant phospholipase A(2) from Naja nigricollis venom binds to coagulation factor Xa to inhibit the prothrombinase complex. Arch Biochem Biophys. 1999; 369(1):107-13. DOI: 10.1006/abbi.1999.1345. View

Sekhar C, Chakrabarty D . Fibrinogenolytic toxin from Indian monocled cobra (Naja kaouthia) venom. J Biosci. 2011; 36(2):355-61. DOI: 10.1007/s12038-011-9068-3. View

Kini R, Evans H . A model to explain the pharmacological effects of snake venom phospholipases A2. Toxicon. 1989; 27(6):613-35. DOI: 10.1016/0041-0101(89)90013-5. View

10.

Offerman S, Smith T, Derlet R . Does the aggressive use of polyvalent antivenin for rattlesnake bites result in serious acute side effects?. West J Med. 2001; 175(2):88-91. PMC: 1071493. DOI: 10.1136/ewjm.175.2.88. View

11.

Shashidharamurthy R, Jagadeesha D, Girish K, Kemparaju K . Variations in biochemical and pharmacological properties of Indian cobra (Naja naja naja) venom due to geographical distribution. Mol Cell Biochem. 2002; 229(1-2):93-101. DOI: 10.1023/a:1017972511272. View

12.

Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

13.

Stefansson S, Kini R, Evans H . The basic phospholipase A2 from Naja nigricollis venom inhibits the prothrombinase complex by a novel nonenzymatic mechanism. Biochemistry. 1990; 29(33):7742-6. DOI: 10.1021/bi00485a024. View

14.

Vishwanath B, Kini R, Gowda T . Purification and partial biochemical characterization of an edema inducing phospholipase A2 from Vipera russelli (Russell's viper) snake venom. Toxicon. 1988; 26(8):713-20. DOI: 10.1016/0041-0101(88)90278-4. View

15.

Wang W, Lu Q, Jin Y, Wei J, Zhu S, Xiong Y . A novel short neurotoxin, cobrotoxin c, from monocellate cobra (Naja kaouthia) venom: isolation and purification, primary and secondary structure determination, and tertiary structure modeling. Comp Biochem Physiol C Toxicol Pharmacol. 2002; 132(1):113-21. DOI: 10.1016/s1532-0456(02)00049-2. View

16.

Mukherjee A, Maity C . Biochemical composition, lethality and pathophysiology of venom from two cobras-- Naja naja and N. kaouthia. Comp Biochem Physiol B Biochem Mol Biol. 2002; 131(2):125-32. DOI: 10.1016/s1096-4959(01)00473-0. View

17.

Qiumin L, Qingxiong M, Dongsheng L, Shaowen Z, Yonghong J, Yuliang X . Comparative study of three short-chain neurotoxins from the venom of Naja kaouthia (Yunnan, China). J Nat Toxins. 2002; 11(3):221-9. View

18.

Daltry J, Wuster W, Thorpe R . Diet and snake venom evolution. Nature. 1996; 379(6565):537-40. DOI: 10.1038/379537a0. View

19.

Mukherjee A . Characterization of a novel pro-coagulant metalloprotease (RVBCMP) possessing alpha-fibrinogenase and tissue haemorrhagic activity from venom of Daboia russelli russelli (Russell's viper): evidence of distinct coagulant and haemorrhagic sites in.... Toxicon. 2008; 51(5):923-33. DOI: 10.1016/j.toxicon.2007.12.008. View

20.

Viravan C, Looareesuwan S, Kosakarn W, Wuthiekanun V, McCarthy C, Stimson A . A national hospital-based survey of snakes responsible for bites in Thailand. Trans R Soc Trop Med Hyg. 1992; 86(1):100-6. DOI: 10.1016/0035-9203(92)90463-m. View